---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-321801"
form_type: "8-K"
ticker: null
cik: "0001403708"
company_name: "Evoke Pharma Inc"
filed_at: "2025-12-17T23:59:59+00:00"
generated_at: "2026-05-16T12:54:13.196776+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# QOL Medical completes $11/share acquisition of Evoke Pharma; delisting and leadership change

## Summary
- Tender offer closed Dec 15 with 67.63% of shares validly tendered; merger completed Dec 17, 2025.
- Shareholders receive $11.00 per share in cash; options and warrants with exercise price below $11 also cashed out.
- Evoke shares to be delisted from Nasdaq; company intends to file Form 15 to terminate SEC registration.
- All directors resigned; CEO, CFO, CMO employment terminated as of Dec 18, 2025; successors from QOL Medical appointed.

## SEC filing metadata
- accession: 0001193125-25-321801
- form_type: 8-K
- cik: 0001403708
- company_name: Evoke Pharma Inc
- filed_at: 2025-12-17T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1403708/000119312525321801/0001193125-25-321801-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1403708/000119312525321801/d81175d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-321801
- JSON: https://secwatch.observer/filing/0001193125-25-321801.json
- Plain text: https://secwatch.observer/filing/0001193125-25-321801.txt

## Source-grounded claims
- claim_id: c23a0387303192a40c8b4616ea7abea36b6c6a17
  claim: Evoke Pharma Inc: Certificate of incorporation amended and restated in connection with merger (effective 2025-12-17).
  evidence_excerpt: Pursuant to the terms of the Merger Agreement, on December 17, 2025, the Company’s certificate of incorporation and bylaws were each amended and restated in their entirety
  evidence_url: https://www.sec.gov/Archives/edgar/data/1403708/000119312525321801/0001193125-25-321801-index.htm
- claim_id: e32b280078473b4cb9272905f9a1aab6c826ee3d
  claim: Evoke Pharma Inc: Bylaws amended and restated in connection with merger (effective 2025-12-17).
  evidence_excerpt: Pursuant to the terms of the Merger Agreement, on December 17, 2025, the Company’s certificate of incorporation and bylaws were each amended and restated in their entirety
  evidence_url: https://www.sec.gov/Archives/edgar/data/1403708/000119312525321801/0001193125-25-321801-index.htm
- claim_id: fc6089c4269fe6187014570458bfda29be82bd25
  claim: Evoke Pharma Inc underwent a change of control involving QOL Medical, LLC for $11.00 in cash per Company Share (closed 2025-12-17).
  evidence_excerpt: Sub commenced a tender offer (the “Offer”) to purchase all of the outstanding shares of common stock, par value $0.0001 per share, of the Company (the “Company Shares”), for $11.00 in cash per Company Share, without interest and subject to any withholding of taxes required by applicable legal requirements (the “Offer Price”). The Offer and related withdrawal
  evidence_url: https://www.sec.gov/Archives/edgar/data/1403708/000119312525321801/0001193125-25-321801-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.